XT
HAE icon

XTX Topco’s Haemonetics HAE Stock Holding History

XTX Topco’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
29,442
-58,495
-67% -$3.76M 0.03% 1025
2026
Q1 		$4.96M Buy
87,937
+76,738
+685% +$5M 0.09% 287
2025
Q4 		$898K Buy
11,199
+6,307
+129% +$424K 0.02% 1103
2025
Q3 		$238K Sell
4,892
-915
-16% -$56.6K 0.01% 1699
2025
Q2 		$433K Sell
5,807
-24,831
-81% -$1.64M 0.02% 1195
2025
Q1 		$1.95M Buy
+30,638
New +$2.08M 0.1% 267
2024
Q4 		– Sell
-8,450
Closed -$679K – 2533
2024
Q3 		$679K Buy
8,450
+3,880
+85% +$313K 0.05% 616
2024
Q2 		$378K Sell
4,570
-2,660
-37% -$234K 0.03% 819
2024
Q1 		$617K Buy
+7,230
New +$567K 0.08% 365
2023
Q4 		– Sell
-5,727
Closed -$513K – 1786
2023
Q3 		$513K Sell
5,727
-873
-13% -$77.9K 0.09% 387
2023
Q2 		$562K Buy
6,600
+3,001
+83% +$254K 0.1% 304
2023
Q1 		$298K Sell
3,599
-64
-2% -$5.18K 0.06% 654
2022
Q4 		$288K Buy
+3,663
New +$294K 0.06% 614
2021
Q3 		– Sell
-5,096
Closed -$340K – 825
2021
Q2 		$340K Buy
5,096
+2,289
+82% +$162K 0.11% 310
2021
Q1 		$312K Buy
+2,807
New +$347K 0.15% 258

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's HAE Position: Q2 2026 in Review

XTX Topco reduced its Haemonetics (HAE) stake by 67% in Q2 2026, selling an estimated $3.76M and leaving 29,442 shares worth $2.21M. The position accounts for 0.03% of the portfolio, ranked #1025.

XTX Topco first reported a position in HAE in Q1 2021 and has held it in 15 quarters since. The position peaked at $4.96M in Q1 2026. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • XTX Topco held 29,442 shares of Haemonetics worth $2.21M as of Q2 2026.
  • XTX Topco sold 58,495 Haemonetics shares in Q2 2026, an estimated $3.76M.
  • Haemonetics made up 0.03% of XTX Topco's portfolio in Q2 2026, its #1025 holding.
  • XTX Topco first reported a position in Haemonetics in Q1 2021 and has held it in 15 quarters since.
  • XTX Topco's Haemonetics position peaked at $4.96M in Q1 2026.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.